Korean Market
OWNR
Mezzion Pharma
★

CEO Donghyun Park Increases Stake via Open Market Purchases but Ownership Dips to 6.05% Due to Share Count Rise

 
OWNR
Mezzion Pharma
★

Mezzion Pharma CEO Park Donghyun Increases Stake Through Open Market Purchases, Maintains 6.09% Ownership

 
OWNR
Mezzion Pharma
★

Mezzion CEO Donghyun Park Increases Stake via Open Market Purchases but Ownership Percentage Decreases Due to Share Dilution

 
MATR
Mezzion Pharma
★

Decision to Acquire 4.2 Billion Won Own Convertible Bonds Before Maturity, Potential Cancellation to Reduce Dilution

 
MATR
Mezzion Pharma
★

Acquisition of 400M Won Own CB Before Maturity, Conversion Price 39,284 Won

 
EXCH
Mezzion Pharma
★★

Appeal Filed for KRW 47.1 Billion Damage Claim

 
PERI
Mezzion Pharma
★

Mezzion 2026 Q1 Loss Widens, Pipeline Progress Continues

 
EXCH
Mezzion Pharma
★

Completion of 6th Unsecured Private Convertible Bond Issuance of KRW 36.5 Billion

 
MATR
Mezzion Pharma
★

Mezzion Decides to Issue Convertible Bonds with Put/Call Options